Peter Doukas
In 1990, Peter Doukas was appointed Acting Dean of the School of Pharmacy and, in 1993, he was appointed Dean. Between 1997 and 2004 he also served concurrently as Acting Dean of the College of Health Professions, during which time the College expanded from four departments based at the Health Sciences Center (HSC) to seven departments spanning the HSC and Main Campus.
During his tenure at the School of Pharmacy, the professional program has transitioned to the entry-level Doctor of Pharmacy (Pharm.D.); the MS Program in Quality Assurance/Regulatory Affairs (QARA) has grown to become the most recognized and largest of its type in the nation; the Pharmaceutical Sciences graduate program has been restructured; the faculty has been strengthened as well as increased in number, research productivity and clinical practice; development activities have expanded and approximately 80% of the physical plant has been transformed. Recently, the school established several discrete laboratory initiatives: the Pharmacokinetics/Bioanalysis Lab; the c-GMP Tableting Facility; the Jayne Haines Center for Pharmacogenomics and Drug Safety; and the Moulder Center for Drug Discovery. In spring 2009 the QARA Program began delivering courses to the National University of Singapore.
In fall 1971 he was appointed Assistant Professor at the Temple University School of Pharmacy, where he taught medicinal chemistry and pharmacology, and he began a medicinal synthesis research program. He is now a Professor of Medicinal Chemistry. In 1977 he received the Lindback Award for Outstanding Teaching. In the 1980’s he began research collaborations with colleagues in the School of Medicine. He has co-authored approximately 60 peer-reviewed papers, chapters and research presentations. In 1990 he was the Temple recipient of the AACP Outstanding Teacher Award.
In 2003 he received the Distinguished Alumnus Award from St. John’s University.
Dr. Doukas received Bachelor’s and Master’s degrees in Pharmacy from St. John’s University in Queens, New York, and his PhD in Medicinal Chemistry from Temple University. He completed post-doctoral research at the Borstel Institute for Experimental Biology and Medicine in Germany, and the Pharmacology Institute at the University of Nijmegen, the Netherlands